Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.

about

Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.

Item

http://www.wikidata.org/entity/Q43698781

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Resource use and cost implicat ...... atrial fibrillation patients.

@en

Resource use and cost implicat ...... atrial fibrillation patients.

@nl

type

Item

label

Resource use and cost implicat ...... atrial fibrillation patients.

@en

Resource use and cost implicat ...... atrial fibrillation patients.

@nl

prefLabel

Resource use and cost implicat ...... atrial fibrillation patients.

@en

Resource use and cost implicat ...... atrial fibrillation patients.

@nl

P1476

Resource use and cost implicat ...... atrial fibrillation patients.

@en

P2093

Christy Fang

http://www.w3.org/2001/XMLSchema#string

Siddhesh Kamat

http://www.w3.org/2001/XMLSchema#string

Winghan Jacqueline Kwong

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

The impact of the Medicare Part D prescription benefit on generic drug use

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Subtherapeutic INR values associated with a switch to generic warfarin.

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

P304

1609-1616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1Q472

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23150608

http://www.w3.org/2001/XMLSchema#string